Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Solvent Exposure Poses Health Risk for Pathology Workers

By LabMedica International staff writers
Posted on 07 Jul 2011
Pathologists and laboratory technicians who handle organic solvents such as toluene and xylene are at increased risk of developing autoimmune connective tissue diseases.

A new study showed an occupational health hazard involving solvent use and Raynaud’s phenomenon (RP). More...
Other studies overseas have shown similar solvent associations, but not with people exposed to solvents at work.

“Our study of 341 medical laboratory workers indicates they are more likely to develop a condition called Raynaud’s phenomenon, if they are exposed to solvents such as toluene or xylene. This raises concerns they could then have further serious health complications later in life,” said lead investigator Gordon Purdie, at the department of medicine, University of Otago, (Wellington, New Zealand).

Raynaud’s phenomenon is characterized by vasoconstriction, or the narrowing of blood vessels in the hands and other extremities, and is characterized by pain, color changes, and tautness or fullness of the fingers or toes. For some people it is a symptom or precursor of scleroderma, a rare connective tissue disease affecting multiple systems in the body and mainly among women.

Lab workers who worked with acetone or chlorinated solvents, combined with xylene or toluene, doubled their risk of developing RP. Risk of developing severe RP was even greater, in fact nine times.

The mainly female laboratory workers (79%) who used solvents in this study had higher rates of RP. Those who had worked with xylene or toluene doubled their risk of developing severe RP.

The study was presented at the Australian Rheumatology Association Scientific Meeting in Brisbane (QLD, Australia), which was held from May 14-17, 2011. The study also appeared online in the June 2011 issue of the Journal of Rheumatology.

Related Links:

University of Otago


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.